During the past decade, Nightingale Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nightingale Hospital" are "Buerger's Disease" (1 trials), "Critical Limb Ischemia" (1 trials), "Critical Limb Ischemia Due to Buerger's Disease" (1 trials) and "Partial Epilepsy" (1 trials). Many other conditions were trialed in "Nightingale Hospital" in a lesser frequency.

Most popular intervention types in "Nightingale Hospital" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Allogeneic Mesenchymal Stem Cells" (1 trials), "Placebo" (1 trials), "Stempeucel(R)" (1 trials) and "YKP3089" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nightingale Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Nightingale Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nightingale Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nightingale Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".